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X-linked recessive myotubular myopathy (XLMTM) is a severe congenital muscle disorder caused by 
mutations in the MTM1 gene and characterized by severe hypotonia and generalized muscle weakness 
in affected males. It is generally a fatal disorder during the neonatal period and early infancy. The 
diagnosis is based on typical histopathological findings on muscle biopsy, combined with suggestive 
clinical features. We experienced a case of a newborn who required intubation and ventilator care 
because of profound hypotonia and respiratory difficulty. The preliminary diagnosis at the time of 
request for retrieval was hypoxic ischemic encephalopathy, but the infant was clinically reevaluated 
for generalized weakness and muscle atrophy. Muscle biopsies showed variability in fiber size and 
centrally located nuclei in nearly all the fibers. We detected an MTM1 gene mutation of c.1261-1C>A 
in the intron 10 region, and diagnosed the neonate with myotubular myopathy. The same mutation was 
detected in his mother.
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Introduction
Myotubular myopathy (MTM) is an X-linked congenital disorder (XLMTM) that is 
caused by MTM1 mutation
1). In this condition, the small muscle fibers present a central 
area devoid of myofibrils and mitochondrial aggregates around the centrally located, 
often large nuclei
2). Compared with other congenital myopathies, patients with XLMTM 
have a rather homogeneous clinical presentation
3). The onset of clinical signs is typically 
at or near birth, and affected infants are areflexic and floppy, exhibiting respiratory 
difficulty that usually requires ventilatory support
4). Respiratory insufficiency often 
complicates the clinical course and causes death among patients
5). Most of these patients 
die during infancy or early childhood
3).
The majority of mutations related to XLMTM have been identified in exons 3, 4, 8, 9, 
11, and 12
6,7). Several cases have been reported since MTM was first described in 1986 in 
Korea
8,9). However, only one case was reported with regard to the genetic analysis of MTM 
in the Korean population
10). Here we report a case of myotubular myopathy in a neonate 
with a splice site mutation of MTM1 gene at the intron 10 region.http://dx.doi.org/10.3345/kjp.2013.56.3.139
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Case report
A 2,930 gm male was born at 37 weeks and 5 days gestation 
age via emergency cesarean section in a local hospital. He was 
the first child of healthy parents. Polyhydramnios and reduced 
fetal movements were noted during the antenatal period. During 
the therapeutic amniocentesis in response to polyhydramnios, 
placental abruption occurred and fetal distress was observed. 
His Apgar scores were 1-5-5 at 1, 5, and 10 minutes; he required 
resuscitation and intubation due to poor respiration.
Subsequently, he was transferred to Pusan National University 
Yangsan Hospital and was placed on ventilator support. His 
birth weight (2,930 g, 50th percentile), length (51 cm, 75th to 
90th percentile), and head circumference (35 cm, 90th percentile) 
were within the normal range. He had no abnormalities based on 
the chest radiograph, but findings showed fractures on both his 
humerus which were splinted for treatment within one month 
(Fig. 1).  
The child’s initial features were similar with the effects of 
birth asphyxia. His birth condition presented severe hypotonia, 
suck¬ing impairment, and the absence of spontaneous move-
ments. He then required mechanical ventilation from birth 
throughout his confinement at the hospital due to apnea.
However, magnetic resonance imaging of the brain and 
electroencephalography showed no evidence of hypoxic ische-
mic encephalopathy. Postnatal blood gas analysis showed 
normal levels; echocardiography and screening blood tests for 
metabolic disease were also normal. 
His generalized hypotonia with absent deep tendon reflexes 
continued. No neonatal reflexes could be elicited and his posture 
was extremely floppy-frog like characterized by a long face (Fig. 
2). Tests for congenital hypotonic disorders, including spinal 
muscular atrophy, myotonic dystrophy, Pompe disease, Prader-
Willi syndrome, and chromosomal disease were carried out. 
However, all tests yielded negative findings. Muscle biopsy of 
the left biceps was performed and myotubular myopathy was 
confirmed based on the findings characterized by large centrally 
placed nuclei in myofibers (Fig. 3). Peripheral blood samples 
for the gene study were obtained from the patient and from his 
mother for X-linked myotubular myopathy. A mutation c.1261-
1C>A was identified in the intron 10 of the MTM1 gene in this 
case. His mother was also noted to have the same mutation (Fig. 4). 
He needed tube feeding for nutritional support and a tracheo-
stomy for ventilator support. He was discharged after six months 
Fig. 1. On infantogram fractures on both humeri were observed.
Fig. 2. The patient manifesting a frog-like posture, long face, and 
undescended testes.
Fig. 3. H&E staining (×200) under light microscopy showing centrally 
located nuclei in nearly all the fibers, with marked variation in fiber size.141 http://dx.doi.org/10.3345/kjp.2013.56.3.139
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and was brought home with a mechanical ventilation support. 
He later died when he was seven months old due to respiratory 
failure. 
1. DNA isolation and PCR reaction
Genomic DNA was isolated from peripheral blood using 
QuickGene DNA kit (Fujifilm life Science, Tokyo, Japan). To 
analyze of MTM1 gene mutation, polymerase chain reaction 
(PCR) was performed by use of fourteen sets of primers designed 
in intronic flanking region containing all exons referred to 
GenBank accession number NT_011726.13. PCR was carried out 
30 cycles. After amplification, PCR mixtures were run on 1.2% 
agarose gel in the presence of ethidium bromide to verify the size 
and purity of PCR products.
2. DNA sequence analysis
After verifying that single specific PCR product was amplified, 
DNA sequencing was performed using the same primers used 
in PCR, and BigDye Terminatore V3.1 Cycle Sequencing 
kit (Applied Biosystems, Foster city, CA, USA) according to 
manufacturer's instructions. Reaction was performed 30 cycles. 
Electrophoresis and analysis of the reaction mixtures were done 
with ABI 3130xl Genetic analyzer.
Discussion
Mutations in the MTM1 gene encoding myotubularin cause 
XLMTM, a well-defined subtype of human centronuclear myo-
pathy
4). XLMTM is characterized by the early onset and presence 
of uniformly small muscle fibers with centrally placed nuclei
3,4). 
Although centrally located nuclei can be found in many myo-
pa  thies, clinical, genetic, and pathological factors can help 
distinguish these myopathies from XLMTM
4). 
Clinical characterization of XLMTM has been comprehensive 
and the disorder has been found to give rise to a severe phenotype 
in males. The most notable clinical manifestations of XLMTM are 
muscle weakness and associated disabilities. It is present at birth 
with marked weakness and hypotonia, external ophthalmoplegia 
and respiratory failure due to the weakness of the muscles res-
ponsible for respiration
11). Signs of antenatal onset include reduc-
ed fetal movements, polyhydramnios and thinning of ribs as 
seen on chest radiographs
11); However, these manifestations are 
rarely observed in other congenital myopathies. Birth as phyxia 
may be the presenting feature
12). Many people tend to confuse 
XLMTM with birth asphyxia during initial detection.  
The diagnosis of XLMTM has traditionally relied upon the 
identification of characteristic histopathologic changes in muscle 
samples from affected males. Because of the time required for 
molecular analysis of MTM1, the clinical diagnosis of XLMTM 
continues to rely upon muscle biopsy
13). Hematoxylin and eosin-
stained cross sections of XLMTM muscle show increased variability 
in fiber size, but this is generally not as extreme as what is seen 
in the dystrophic processes. The myofibers typically appear small 
and have a rounded profile. The cardinal histopathologic feature of 
XLMTM is the presence of hypotrophic myofibers with relatively 
large, centrally placed nuclei
3). This case was also confirmed as 
XLMTM by muscle biopsy. 
Fig. 4. DNA sequence electropherograms of the patient and his mother, showing the 
identified MTM1 mutations in intron 10. (A) Normal DNA sequence, (B) patient’s DNA 
sequence showing the c.1261-1G>A mutation, and (C) his mother’s DNA sequence 
showing a heterozygous mutation of c.1261-1G>A.http://dx.doi.org/10.3345/kjp.2013.56.3.139
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The X-linked nature of this disorder facilitated genetic analy-
sis, with linkage studies assigning the gene to Xq28 in 1990
11). 
Laporte et al.
1) isolated the MTM1 gene by positional cloning and 
named the gene product, ‘myotubularin’. In 1997, de Gouyon et 
al.
14) and Laporte et al.
15) carried out a complete gene sequencing of 
15 coding exons and flanking intron. In several series, mutations 
were detected in 60% to 90% of individuals with XLMTM
14,15). The 
majority of mutations were identified in exons 3, 4, 8, 9, 11, and 
12
6,7). 
The first report concerning an XLMTM family with two affect-
ed infants diagnosed by muscle biopsy and gene analysis was 
released in Korea
8). A nonsense mutation Arg486STOP was iden-
tified in exon 7 of the MTM1 gene in that family. Moreover, we 
detected another splice site mutation of MTM1 gene c.1261-1C>A 
at the intron 10 region in a present neonate with XLMTM. 
Although, the diagnosis is confirmed by muscle biopsy, MTM1 
mutation analysis is critical in consulting with the mother about 
prenatal family planning and antenatal genetic screening. Pre-
natal testing should still be offered to all women who might give 
birth to affected male infants
3). 
There is no known treatment for such disorder
16). The manage-
ment is essentially supportive and/or rehabilitative, requiring a 
multidisciplinary approach
11,17). In the majority of cases, the course 
is fatal within the initial months of life, but a proportion of affected 
males infants may survive into their teens or beyond 
11,18,19).  
Floppy infants can be misdiagnosed with hypoxic ischemic 
encephalopathy at birth. Therefore, physicians who care for the 
newborn should consider the possibility that a neuromuscular 
disorder might be present in a hypotonic infant. When a floppy 
infant is regarded to have hypoxic ischemic encephalopathy 
based on a perinatal circumstantial evidence, an accurate diag-
nosis should be established by carrying out appropriate clinical 
procedures. If a neuromuscular disorder is suspected, a muscle 
biopsy should be done. A gene study of a patient diagnosed with 
MTM is essential for genetic counseling. 
We report that a neonate initially misdiagnosed with hypoxic 
ischemic  encephalopathy was diagnosed with a XLMTM with a 
splice site mutation of MTM1 gene at the intron 10 region. 
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